Apimeds Pharmaceuticals US (APUS) Change in Accured Expenses (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Change in Accured Expenses of $448494.0 for Q3 2025, up 154.96% on a QoQ basis from -$816064.0 in Q2 2025, and up 296.45% year-over-year from $113128.0 in Q3 2024.
Apimeds Pharmaceuticals US (APUS) Change in Accured Expenses (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $448494.0 for Q3 2025.
- Quarterly Change in Accured Expenses rose 296.45% year-over-year to $448494.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $151675.0 (changed N/A YoY) and the FY2024 annual result came in at $536752.0, up 904.48% from the prior year.
- Change in Accured Expenses was $448494.0 for Q3 2025 at Apimeds Pharmaceuticals US, up from -$816064.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $448494.0 in Q3 2025 and bottomed at -$816064.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Apimeds Pharmaceuticals US | 8.17 Mn | 8.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 448,494.00 |
| Sep 30, 2025 | 448,494.00 |
| Jun 30, 2025 | -816,064.00 |
| Jun 30, 2025 | -816,064.00 |
| Mar 31, 2025 | 344,012.00 |
| Mar 31, 2025 | 344,012.00 |
| Dec 31, 2024 | 175,233.00 |
| Dec 31, 2024 | 175,233.00 |
| Sep 30, 2024 | 113,128.00 |
| Sep 30, 2024 | 113,128.00 |
| Jun 30, 2024 | 243,184.00 |
| Jun 30, 2024 | 243,184.00 |
| Mar 31, 2024 | 5,207.00 |
| Mar 31, 2024 | 5,207.00 |